首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Des-Arg9-bradykinin-induced increases in intracellular calcium ion concentration in single bovine tracheal smooth muscle cells.
【2h】

Des-Arg9-bradykinin-induced increases in intracellular calcium ion concentration in single bovine tracheal smooth muscle cells.

机译:Des-Arg9-缓激肽诱导的单个牛气管平滑肌细胞内细胞内钙离子浓度增加。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Dynamic video imaging was used to measure the des-Arg9-bradykinin-induced changes in the intracellular free calcium ion concentration ([Ca2+]i) of single bovine tracheal smooth muscle (BTSM) cells. 2. In the presence of extracellular calcium ions, des-Arg9-bradykinin (1 nM-10 microM) produced a concentration-dependent increase in the [Ca2+]i over basal levels yielding an EC50 value of 316 nM. The percentage of cells responding to each concentration of des-Arg9-bradykinin also increased in a concentration-dependent manner (from 9% to 100%). 3. The bradykinin B2 receptor antagonist, D-Arg[Hyp3,Thi5,8,D-Phe7]-bradykinin (10 microM), was without effect on the calcium response of the cells when added 2 min prior to des-Arg9-bradykinin (100 nM). However, the B1 receptor antagonist, des-Arg9Leu8-bradykinin (10 microM), completely abolished the des-Arg9-bradykinin-induced response. 4. Under calcium-free conditions, des-Arg9-bradykinin induced an increase in [Ca2+]i at concentrations of 1 microM and 10 microM. The response to 10 microM des-Arg9-bradykinin was reduced by preincubation of either D-Arg[Hyp3, Thi5,8,D-Phe7]-bradykinin (10 microM) or des-Arg9Leu8-bradykinin (10 microM). 5. We conclude that bradykinin B1 receptors are expressed by cultured BTSM cells and mediate the des-Arg9-bradykinin-induced influx of calcium ions at low agonist concentrations (< 1 microM). At higher concentrations, des-Arg9-bradykinin (1 microM and 10 microM) can stimulate both B1 and B2 receptors to effect intracellular calcium release under calcium-free conditions.
机译:1.动态视频成像用于测量des-Arg9-缓激肽诱导的牛单支气管平滑肌(BTSM)细胞胞内游离钙离子浓度([Ca2 +] i)的变化。 2.在存在细胞外钙离子的情况下,des-Arg9-缓激肽(1 nM-10 microM)在基础水平上产生[Ca2 +] i浓度依赖的增加,从而产生316 nM的EC50值。响应每种浓度的des-Arg9-缓激肽的细胞百分比也以浓度依赖性方式增加(从9%到100%)。 3.缓激肽B2受体拮抗剂D-Arg [Hyp3,Thi5,8,D-Phe7]-缓激肽(10 microM)在加入des-Arg9-缓激肽前2分钟对细胞的钙反应没有影响。 (100 nM)。但是,B1受体拮抗剂des-Arg9Leu8-缓激肽(10 microM)完全消除了des-Arg9-缓激肽诱导的应答。 4.在无钙条件下,des-Arg9-缓激肽在1 microM和10 microM的浓度下诱导[Ca2 +] i的增加。通过预孵育D-Arg [Hyp3,Thi5,8,D-Phe7]-缓激肽(10 microM)或des-Arg9Leu8-缓激肽(10 microM),降低了对10 microM des-Arg9-缓激肽的反应。 5.我们得出结论,缓激肽B1受体由培养的BTSM细胞表达,并在低激动剂浓度(<1 microM)下介导des-Arg9-缓激肽诱导的钙离子流入。在更高的浓度下,des-Arg9-缓激肽(1 microM和10 microM)可以刺激B1和B2受体在无钙条件下影响细胞内钙的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号